Mannitol - Potential Role in Hemodialysis Initiation for Reduction of Intra-dialytic Hypotension

Intra-dialytic Hypotension Clinical Trial

Official title:
Pilot Study of Intravenous Mannitol During Hemodialysis Initiation to Reduce the Occurrence of Intra-dialytic Hypotension.

Status Completed

Clinical Trial Summary

Kidney failure can result from a variety of conditions and can be temporary or permanent. Hemodialysis is available as a replacement treatment to perform the work that the kidneys normally do. However, the dialysis procedure can be associated with rapid changes in the composition of the blood - this may lead to changes in blood pressure and in turn reduced blood supply to important parts of the body. We aim to investigate if giving a medicine (called mannitol) during dialysis may be able to reduce the frequency of these low blood pressure events.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01520207
Study type	Interventional
Source	Brigham and Women's Hospital
Contact
Status	Completed
Phase	Phase 2
Start date	May 2012
Completion date	December 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02145260` - Trial of Dialysate Sodium in Chronic Hospitalized Hemodialysis Patients	N/A
Completed	`NCT03397992` - Low Dialysate Temperature During SLED	N/A
Completed	`NCT03144817` - Dialysate Sodium Lowering Trial	Phase 2
Not yet recruiting	`NCT03870594` - IDH in Diabetic Haemodialysis Patients and Association With Dialytic Age
Completed	`NCT03856151` - To Evaluate the Effects of Heating Device (Electronic Moxibustion) in Patients With Intradialytic Hypotension	N/A